Cardiomedex is a highly skilled preclinical CRO specialized in the cardiovascular field. Cardiomedex conducts reliable studies that optimize the preclinical development of drug candidates for the treatment of cardiovascular diseases and cardiometabolic complications. Our large selection of gold standard animal models covers cardiovascular disorders such as: Heart failure with preserved or reduced ejection fraction Myocardial infarction Cardiac hypertrophy Hypertension Endothelial dysfunction Anthracycline cardiotoxicity Along with in vivo models, we offer a state-of-the-art platform for functional exploration & pharmacological characterization using ex-vivo and in vitro assays. In addition to CRO services, we provide our clients with personalized consulting services in line with the pharma industry’s emerging trends.